Using genetic probes and fluorescent scanning, the firm plans to market the $20 test for pathogens that cause urinary tract infections and biological warfare.
The company plans to launch the system this summer in Europe, aiming to broaden cell-free DNA screening for trisomy 21, 18, and 13.
Fusion originally developed its synthetic capture probe technology for cancer gene fusion assays but is repurposing it to diagnose infectious diseases.
The approach, published earlier this week in Nature Biomedical Engineering, uses long-adapter single-strand oligonucleotide (LASSO) probes.
The authors have plans to turn the technology into a kit for sequencing panels to be developed by their startup firm, Searna.
The structured oligonucleotide probe could allow simultaneous PCR amplification and microarray hybridization, and could enable universal microarrays.
NEW YORK (GenomeWeb News) – Biosearch Technologies said today that it has acquired the oligonucleotide manufacturing division of DNA Technology for an undisclosed amount.
NEW YORK (GenomeWeb News) – AITbiotech has received ISO 13485:2003 certification for its labs in Singapore that offer genomics services and molecular diagnostic testing.
NEW YORK (GenomeWeb News) – Agilent Technologies today announced a deal with BioDiscovery allowing that firm's customers access to Agilent SureFISH probes directly from BioDiscovery's Nexus software.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Enzo Life Sciences this week sued Abbott, Becton Dickinson, and Hologic claiming those companies infringe Enzo's patent covering a method of modifying nucleotides for use as probes.
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.